Zoetis Gains EU Approval for Portela® to Treat Osteoarthritis Pain in Cats

Zoetis Receives EU Approval for Portela® (relfovetmab), the First Three-Month Monoclonal Antibody Therapy for Osteoarthritis Pain in Cats Zoetis Inc. (NYSE: ZTS), the world leader in animal health, today annonced that the European Commission has granted marketing authorization for Portela®…

Read MoreZoetis Gains EU Approval for Portela® to Treat Osteoarthritis Pain in Cats
Clean Harbors Reports Financial Results for the Third Quarter of 2025

Clean Harbors Reports Financial Results for the Third Quarter of 2025

Clean Harbors Reports Strong Third-Quarter 2025 Results, Highlights Continued Growth and Margin Expansion Clean Harbors, Inc. (“Clean Harbors” or the “Company”) (NYSE: CLH), the leading provider of environmental and industrial services across North America, today announced financial results for the…

Read MoreClean Harbors Reports Financial Results for the Third Quarter of 2025

FUJIFILM Biotechnologies’ Lars Petersen Wins 2025 CPHI “CEO of the Year

FUJIFILM Biotechnologies’ CEO Lars Petersen Named “CEO of the Year” at CPHI Pharma Awards 2025 FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) specializing in biologics, vaccines, and advanced therapies, proudly announces that its President and Chief Executive…

Read MoreFUJIFILM Biotechnologies’ Lars Petersen Wins 2025 CPHI “CEO of the Year

Element Solutions to Acquire Micromax® from Celanese for $500 Million

Element Solutions to Acquire Micromax® from Celanese in $500 Million Deal, Expanding Leadership in Advanced Electronics Materials (“Element Solutions,” “ESI,” or the “Company”), a global and diversified specialty chemical technology company, announced today that it has entered into a definitive…

Read MoreElement Solutions to Acquire Micromax® from Celanese for $500 Million